|
Open Access-Title
|
Self-Management of COVID-19 at home: A case study of a patient with diabetes and the community health policy on vulnerable groups |
|
|
Author
|
Alexandros Argyriadis, Eleni Kitsiou, Chrisi Vlachou, Agathi Argyriadi Department of Nursing, Frederick University, Nicosia, Cyprus |
|
|
Citation
|
A. Argyriadis, E. Kitsiou, Ch. Vlachou, A. Argyriadi. Self-Management of COVID-19 at home: A case study of a patient with Diabetes and the community health policy on vulnerable groups. Review Clin. Pharmacol. Pharmacokinet. 2023, 37, 2, 63-68. DOI: 10.5281/zenodo.8402065 |
|
|
Publication Date
|
03-10-2023
|
|
|
Full Text Language
|
English |
|
|
Open access article
DOI: 10.5281/zenodo.8402065 |
||
|
Keywords
|
COVID-19, self-management, diabetes, vulnerable groups, community health policy, pandemic response
|
|
|
Other Terms |
Review |
|
|
Summary
|
Introduction: The global COVID-19 pandemic has posed significant challenges to healthcare systems worldwide. Vulnerable populations, such as individuals with underlying health conditions, are particularly at risk. This study focuses on the self-management of COVID-19 at home among patients with diabetes, a high-risk group, and its alignment with community health policies aimed at protecting vulnerable populations. Aim: The aim of this case study was to explore the experiences of a patient with diabetes who self-managed COVID-19 symptoms at home and to analyze the extent to which community health policies address the needs of vulnerable groups in the context of the pandemic. Method: A qualitative case study design was employed to gain in-depth insights into the self-management journey of a patient with diabetes who contracted COVID-19. Semi-structured interviews were conducted with the patient, using a policy review approach. Thematic analysis was utilized to identify key themes in the patient’s experience and policy documents. Results: The findings revealed that the patient faced unique challenges in managing both diabetes and COVID-19 symptoms at home. While the patient demonstrated resourcefulness and adaptability, several barriers emerged, including limited access to healthcare resources and the absence of specific guidelines for vulnerable groups. The analysis of community health policies highlighted the need for more targeted interventions to support vulnerable populations during the pandemic. Conclusions: Self-management of COVID-19 among individuals with diabetes requires tailored support and guidance. Existing community health policies should be updated to address the specific needs of vulnerable groups, ensuring equitable access to resources and information. This case study underscores the importance of a comprehensive and inclusive approach to pandemic response and highlights opportunities to enhance the resilience of healthcare systems in the face of similar challenges in the future. |
|
| References | 1. Vlachou C, Argyriadis A, Argyriadi A. Self-Management of Fear due to the Covid-19 Pandemic and the Changes it has brought to the Every Day Life. Review of Clinical Pharmacology and Pharmacokinetics, International Edition. 2022; 17-22. 2. Iuliano AD, Brunkard JM, Boehmer TK, Peterson E, Adjei S, Binder AM, et al. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. Morbidity and Mortality Weekly Report. 2022; 71(4): 146-152. 3. Xiong X, Lui DTW, Chung MSH, Au ICH, Lai FTT, Wan EYF, et al. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study. PLoS Medicine. 2023; 20(7): e1004274. 4. Gold JA, Ahmad FB, Cisewski JA, Rossen LM, Montero AJ, Benedict K, et al. Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic—National Vital Statistics System, United States, January 2020–December 2021. Clinical Infectious Diseases. 2023; 76(3): e255-e262. 5. Argyriadis A, Andreadaki C, Chalkia M, Agathi A. Studying abroad: social inequalities and challenges during the covid-19 pandemic crisis. Crisis. 2022; 11(3): 149-153. 6. Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC medicine. 2022; 20(1): 1-10. 7. Kastora S, Patel M, Carter B, Delibegovic M, Myint PK. Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysis. Endocrinology, Diabetes & Metabolism. 2022; 5(3): e00338. 8. Kazakou P, Lambadiari V, Ikonomidis I, Kountouri A, Panagopoulos G, Athanasopoulos S, et al. Diabetes and COVID-19; A bidirectional interplay. Frontiers in endocrinology. 2022; 13: 780663. 9. Banerjee M, Pal R, Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Primary Care Diabetes. 2022; 16(4): 591-593. 10. Steenblock C, Hassanein M, Khan EG, Yaman M, Kamel M, Barbir M, et al. Diabetes and COVID-19: short-and long-term consequences. Hormone and Metabolic Research. 2022; 54(08): 503-509. 11. Omame A, Nwajeri UK, Abbas M, Onyenegecha CP. A fractional order control model for Diabetes and COVID-19 co-dynamics with Mittag-Leffler function. Alexandria Engineering Journal. 2022; 61(10): 7619-7635. 12. Yano M, Morioka T, Natsuki Y, Sasaki K, Kakutani Y, Ochi A, et al. New-onset type 1 diabetes after COVID-19 mRNA vaccination. Internal Medicine. 2022; 61(8): 1197-1200. 13. Agius R, Gruppetta M, Aquilina S, Fava S, Gauci C, Gatt A. Knowledge and attitudes regarding diabetes in the Maltese population: a survey. Primary Health Care Research & Development. 2017; 18(1): 64-72. 14. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 2018; 24(6): 1069-1078. |
|
|
Relative Papers
|
||